The IDH1 mutation was higher in cluster1 (77%) than cluster2 (18%), IDH1 mutation dramatically indicated the outcome of glioma patients, so the distinction in IDH1 mutation between two cluster subtypes may be one of the reasons that contribute to the survival of patients [20]. Here, IDH1 is linked to central nervous system cancer.